Leptin regulates body weight by its receptor-mediated anorectic, thermogenic and antisteatotic effects. Recently, lower leptin binding to the soluble form of the leptin receptor (LEPR) was shown in carriers of the Arg223-encoding allele of the Gln223Arg polymorphism of the LEPR. To investigate whether this variant influences energy metabolism and adiposity in Pima Indians, we genotyped non-diabetic Pima Indians in whom we had measured body composition and 24 h energy expenditure (24 h EE), physical activity level (PAL) and 24 h respiratory quotient (24 h RQ) in a respiratory chamber (n ¼ 268) and who had undergone percutaneous fat biopsies from the periumbilical region (n ¼ 184). Genotype was not associated with percent body fat (P > 0.39), but was associated with 24 h EE, PAL and mean subcutaneous abdominal adipocyte size (SAAS all P < 0.05). Homozygotes for the Arg223-encoding allele had lower 24 h EE (P ¼ 0.04) and PAL (P ¼ 0.007), but larger SAAS (P ¼ 0.01) than Gln homozygotes. These findings are consistent with a role of the Gln223Arg polymorphism in reducing peripheral and central leptin binding to the LEPR in humans. However, these effects do not seem to have a major impact on adiposity in this population.
Introduction
Leptin, the product of the ob gene, is primarily secreted by the adipose tissue and it regulates body weight by its receptor mediated anorectic, thermogenic and antisteatotic effects. The leptin receptor (LEPR) is a single-transmembrane-domain receptor of the cytokine-receptor family with widespread tissue distribution and several alternatively spliced isoforms. 1, 2 In the Pima Indians of Arizona, seven polymorphic sites were identified in the LEPR gene. 3 Among these polymorphisms, we found that there was no effect of the Gln223Arg polymorphism on adiposity in a small group of individuals. The Gln223Arg polymorphism of the LEPR, however, was recently found to be associated with a lower binding capacity of leptin to the soluble form of the receptor in plasma which was interpreted as indicating abnormal receptor function. 4 Based on this new information, we tested whether the Gln223Arg polymorphism of the LEPR was associated with adiposity, energy expenditure, physical activity level and metabolism of the adipose tissue in a large group of non-diabetic Pima Indians.
Subjects and methods
Pima Indians (Table 1) participating in ongoing studies on the pathogenesis of obesity and type 2 diabetes were studied. In 268 non-diabetic subjects (group 1) who were genotyped for the Gln223Arg polymorphism of the leptin receptor, we had measurements of 24 h energy expenditure (24 h EE) and respiratory quotient (24 h RQ; estimate of whole body carbohydrate=lipid oxidation rate). A group of 184 non-diabetic subjects (group 2) had percutaneous fat biopsies from the periumbilical region for determination of mean subcutaneous abdominal adipocyte size (SAAS).
Body composition was estimated by underwater weighing with determination of residual lung volume by helium dilution, 5 or by total body dual energy X-ray absorptiometry (DPX-L; Lunar Corp., Madison, WI, USA). 6 Glucose and insulin concentrations were determined after fasting and also measured 2 h after glucose ingestion for assessment of glucose tolerance. Fasting plasma leptin concentrations were measured by solid-phase sandwich enzyme radioimmunoassay using an affinity-purified polyvalent antibody immobilized in microtiter wells. The concentration of leptin in samples was calculated from a standard curve generated in each assay with recombinant human leptin. This assay is sensitive to leptin concentrations of 20 pg=ml and the coefficient between duplicate measurements is 0.96.
The measurement of energy expenditure and substrate oxidation in the respiratory chamber has previously been described. 7 The level of physical activity was calculated by dividing the 24 h EE by the sleeping metabolic rate. 8 The procedures for fat biopsy, assessment of adipocyte size 9 and genotyping the LEPR gene have been previously described 3 in detail.
Statistical analyses were performed using the software of the SAS Institute (Cary, NC, USA). Differences in 24 h EE, PAL and SAAS between genotypes were tested with generalized estimating equation regression models that account for nonindependence within nuclear family membership and thus allow for tests of association that include all individuals in a sibship. 10 In these analyses, 24 h EE, PAL and SAAS were the dependent variables, whereas age, sex, body composition, energy balance, degree of Pima Indian heritage and genotype (Gln=Gln, Gln=Arg and Arg=Arg) were the independent variables. The overall effect of genotype on the dependent variable was assessed by the multivariable Wald Statistic (w 2 with 2 d.f.), which is derived from the regression coefficients and their covariance matrix.
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Results
The frequency of the 223Arg encoding allele was 0.32 in group 1 and 0.33 in group 2, respectively. The genotype distribution was in Hardy -Weinberg equilibrium in both groups (P ¼ 0.82 group 1, P ¼ 0.92 group 2, (w 2 Test)). There were no differences in age, height, weight, body mass index, percentage body fat, fat mass and fat-free mass and fasting plasma leptin concentrations among the three genotypes in group 1 (Table 1) . However, subjects homozygous for the Arg223-encoding allele had lower 24 h EE (2133 AE 363 kcal=day) compared with the other genotypes (2365 AE 395 kcal=day (P ¼ 0.04, Gln=Gln) and 2359 AE 413 kcal=day (P ¼ 0.008, Gln=Arg)) and a lower PAL (1.36 AE 0.09) compared with the Gln homozygotes (1.43 AE 0.11 (P ¼ 0.007, Gln=Gln); Figure 1A ,B). There was no consistent effect of genotype on 24 h RQ (0.846 AE 0.023, Gln=Gln; 0.855 AE 0.022, Gln=Arg; and 0.849 AE 0.027, Arg=Arg).
Subjects homozygous for the Arg223-encoding allele had a higher subcutaneous abdominal adipocyte size (0.96 AE 0.2 mg lipid=cell) compared with the other two genotypes (0.78 AE 0.2 mg lipid=cell, (P ¼ 0.01, Gln=Gln) and 0.75 AE 0.2 mg lipid=cell (P ¼ 0.005, Gln=Arg); Figure 1C ). The significant difference in fat-free mass in group 2 is a direct consequence of the sex distribution mismatch between the genotypes. As there was clearly no difference in fat-free mass in the larger group, we consider this an artifact.
Discussion
We determined whether the Gln223Arg polymorphism of the LEPR was associated with adiposity, energy metabolism Leptin receptor and energy metabolism N Stefan et al and fat cell size in Pima Indians. There was no association of this variant with adiposity but subjects homozygous for the Arg223-encoding allele had a lower 24 h EE, a lower PAL, and a higher SAAS compared to those homozygous for the Gln223-encoding allele. Recently, a lower leptin binding capacity to the soluble LEPR in plasma was shown in postmenopausal Caucasian women carrying the Arg223-encoding allele. This was accompanied by a higher body mass index, fat mass and plasma leptin concentration. 4 Although it is unclear how the soluble form of the LEPR reflects the function of the transmembrane LEPR in various tissues, it has been speculated that subjects having this variant in the LEPR-gene might also have a form of leptin resistance.
In animals, leptin was shown to be involved in the regulation of energy expenditure. 12 Although similar results in humans are inconsistent, 13, 14 impaired leptin signalling might also be expected to be associated with lower 24 h EE. In our analysis, subjects homozygous for the Arg223-encoding allele have the lowest 24 h EE, with and without adjustment for determinants such as age, sex, fat mass and fat-free mass.
We found that subjects with the Arg223-encoding allele also had a lower PAL. One of the effects of intra-cerebroventricular leptin administration to animals is the activation of the sympathetic nervous system (SNS). 15 Plasma leptin concentrations were shown to be positively correlated with muscle sympathetic nerve activity in humans. 16 A relationship has also been found between SNS activity and measurements of spontaneous physical activity in humans. 17 Therefore, as leptin seems to play a role in the modulation of SNS-activity in humans, an impaired leptin signalling due In addition to its central effects on metabolism, leptin has been shown to act on peripheral tissues. Leptin induces lipolysis in adipocytes without increasing the release of free fatty acids and increases lipid oxidation. 18 In our study, the Gln223Arg polymorphism of the LEPR does not seem to have an effect on whole body lipid oxidation measured by 24 h RQ, but homozygotes for the Arg223-encoding allele in the LEPR have a higher SAAS. Large fat cells have been shown to be associated with excessive fat storage. 19 Consistent with this, adipocytes from db=db mice, which lack the LEPR, are five times as large as those from normal mice. 20 Although we found an association of the Gln223Arg polymorphism with low 24 h EE and PAL, the present analysis confirms our earlier report 3 that the impact of this polymorphism on whole-body adiposity is modest. The reason for this modest effect is not immediately apparent, given the anorectic properties of leptin. As an intact central leptin action is necessary for these anorectic effects, a concomitant reduction in food intake that would offset the lower energy expenditure cannot be invoked as a possible explanation. Lack of data on food intake represents an obvious limitation of our study.
In conclusion, these findings are consistent with a role of the Gln223Arg polymorphism in reducing peripheral and central signalling of the LEPR in humans. However, these effects do not seem to have a major impact on adiposity in this population. The present data also do not allow for a determination of whether the observed associations are due to direct functional consequences of the Gln223Arg polymorphism or whether it is in linkage disequilibrium with functional polymorphisms in this genomic region. Additional functional studies to clarify the role of the Gln223Arg polymorphism on leptin action in human metabolism are needed.
